North American tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around -0.3% during the forecast period.  High prevalence of tuberculosis along with the favorable health coverage policies in the region is one of the major factors for the growth of the market. According to World Economic Forum North America has one of the strong economies that comprises of 27.95 % of World economy that is one of the factors that affects the healthcare market. Among the two countries the US have higher healthcare expenditure as compared to Canada.  Additionally, stronger growth in spending for private hospital care, physician, health insurance and clinical services has been driving the market growth. Moreover, the healthcare spending and public spending reflects the demand of tuberculosis diagnosis tools and therapeutics and acts as a major motivator of this market.

Visit for Global Tuberculosis Diagnosis and Treatment Market Report at: https://www.omrglobal.com/industry-reports/tuberculosis-diagnosis-and-treatment-market-size

North American tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing. 

The key players that are active in the market include Abbott Laboratories, Akonni Biosystems, Inc., Alere Inc., Becton, Dickinson and Co., Cepheid, Inc, Hologic, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc. and Thermo Fisher Scientific. For instance, recently, in November, 2017, Akonni Biosystems accounted for a receipt of $300K Commercial Readiness Pilot (CRP) grant from the National Institutes of Health (NIH). This grant enabled Akonni for a faster commercialization of its TruArray MDR-TB test on its TruDx 3000 sample-to-answer diagnostic platform. Additionally, the major activity was recorded in October, 2017 when Alere Inc., Massachusetts based rapid point-of-care diagnostics provider got acquired by Abbott Laboratories. Alere's complementary technologies will assist the acquiring company in providing better care for patients.

Research Methodology

The market study of the North American Tuberculosis Diagnosis and Treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Tuberculosis Diagnosis and Treatment  Market Research and Analysis by Drugs Type
2. North American Tuberculosis Diagnosis and Treatment Market Research and Analysis by Diagnosis

The Report Covers

• Comprehensive research methodology of the North American Tuberculosis Diagnosis and Treatment market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American Tuberculosis Diagnosis and Treatment market.
• Insights about market determinants which are stimulating the North American Tuberculosis Diagnosis and Treatment market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.